This Science News Wire page contains a press release issued by an organization
and is provided to you "as is" with little or no review from Science X staff.
Drug-loaded beads may help treat liver cancer
October 6th, 2014
This is a fluorescent micrograph showing the complete loading of idarubicin 10 mg in 2 mL DC Bead 300–500 μm. At the drug/beads contact time, the blue beads were distinguishable within the intensely orange-red idarubicin 10 mg/10 mL solution. At 90 min, the idarubicin solution had a very pale hue and >95% of the drug was present within the beads as revealed by their dark colour. Idarubicin concentrations in the supernatant were measured using reversed-phase liquid chromatography with tandem mass spectrometry. The photograph was taken with an inverted fluorescent microscope (λexcitation = 485 nm) associated with AxoVision image analysis software for acquisition and image processing. Credit: Alimentary Pharmacology and Therapeutics
A new phase 1 safety trial has demonstrated that idarubicin-loaded beads are well tolerated by patients but are toxic to liver cancer cells. Idarubicin is an anthracycline that is currently used to treat leukemias.
Two months into the 21-patient trial, the tumors of 28% of patients had complete responses to the drug, and the tumors of 24% of patients had a partial response. The findings are published in Alimentary Pharmacology and Therapeutics.
More information:
Boulin, M., Hillon, P., Cercueil, J. P., Bonnetain, F., Dabakuyo, S., Minello, A., Jouve, J. L., Lepage, C., Bardou, M., Wendremaire, M., Guerard, P., Denys, A., Grandvuillemin, A., Chauffert, B., Bedenne, L. and Guiu, B. (2014), Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial. Alimentary Pharmacology & Therapeutics, 39: 1301–1313. doi: 10.1111/apt.12746
Provided by Wiley
Citation:
Drug-loaded beads may help treat liver cancer (2014, October 6)
retrieved 16 June 2025
from https://sciencex.com/wire-news/174052596/drug-loaded-beads-may-help-treat-liver-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
This site uses cookies to assist with navigation and analyse your use of our services. Please accept analytics cookies to help us improve.
Learn more in our Privacy Policy
and Terms of Use.